
AbbVie
AbbVie in Fortune Rankings
- About
- Great Place to Work
- Earnings Reports
AbbVie is among the largest pharmaceutical companies by revenue, and provides therapeutic solutions in areas including immunology, oncology, and neuroscience. AbbVie was founded in 2013 as a spinoff from Abbott Laboratories and is best known for blockbuster drugs like Botox and Humira, one of the world’s top-selling pharmaceuticals.

Courtesy of AbbVie
- Company Information
- Best Workplaces For Parents
- Best Companies
- Benefits
- Best Workplaces In Biopharma
- Best Companies To Work For Europe
- Best Workplaces For Women
- World's Best Workplaces
- Best Companies To Work For Southeast Asia
- World's Most Admired Companies
- America's Most Innovative Companies
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Best Workplaces In Chicago
- Updated:7/28/26
- Country/Territory:U.S.
- Headquarters:North Chicago, Ill.
- Industry:Pharmaceuticals
- CEO:Robert A. Michael
- Website:https://www.abbvie.com
- Ticker:ABBV
- Company type:Public
- Revenues ($M):$61,160
- Profits ($M):$4,226
- Market value ($M):$438,165
- Number of employees:57,000
Market value as of July 13, 2026.
- Founded:2013
- Sites:53
- Industry Vertical:Biotechnology
- Rank last year:41
- Years on list:9
- U.S. employees:28,000
- U.S. job openings:1,100
- Year founded:2013
Employees and job openings are U.S.-only.
- Subsidized childcare:Yes
- Compressed work weeks:Yes
- Option to work remotely:Yes
- Minimum requirement in-office attendance (days per week):3
- Mental health coverage:Yes
- Free mental health sessions (per year):10
- Free backup childcare time off (days):-
- Maximum $ amount covered for fertility services:2 smart cycles-fertility/$20,000-adoption/$20,000-surrogacy
- Fully paid maternal leave (days):100
- Fully paid paternal leave (days):60
- Fully paid adoptive leave (days):70
- Maternal leave in addition to regular time off (days):150
- Paid days off for volunteering:Yes
- Founded:2013
- Sites:31
- Industry Vertical:Biotechnology
- Sector:Health Care
- CEO/Top executive:Robert A. Michael
- Group headquarters:U.S.
- HQ location:U.S.
- GPTW national list:Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom
- Woman CEO:no
- Number of Years on List:2
- Industry Vertical:Biotechnology
- Founded:2013
- # Work Sites:53
- World's Best list history:3 on 2024 List
- Countries where the company was recognized on a GPTW national list:Algeria, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Dominican Republic and Caribbean, Egypt, Estonia, Finland, France, Germany, Greater China (Greater China, Hong Kong, Taiwan), Greece, Hungary, Ireland, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Mexico, The Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, Tunisia, UAE, United Kingdom, United States, Uruguay
- Sector:Health Care
- Type of organization:Public
- CEO/Top executive:Robert A. Michael
- Group headquarters:U.S.
- HQ location:North Chicago
- GPTW national list:Malaysia, Philippines, Singapore, Thailand
- Woman CEO:no
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:-
- Previous All-Star Rank:-
- Industry Rank:8
- Previous Industry Rank:8
- Overall Score:6.96
- Innovation:10
- People Management:8
- Use of Corporate Assets:6
- Social Responsibility:13
- Quality of Management:7
- Financial Soundness:7
- Long-Term Investment Value:7
- Quality of Products/Services:5
- Global Competitiveness:12
- Sector:Health Care
- Strongest Dimension:Product innovation
- Years on list:4
- Previous rank:27
- State:Illinois
- $ Millions% change
- Revenues ($M):$61,1608.6%
- Profits ($M):$4,226-1.2%
- Assets ($M):$133,960-
- Total Stockholder Equity ($M):$-3,270-
- Profit as % of Revenues:6.9%
- Profits as % of Assets:3.2%
- Profits as % of Stockholder Equity:-
- Earnings Per Share ($):2.40
- EPS % Change (from prior fiscal year):-1.3%
- EPS % Change (5 year annual rate):-2.8%
- EPS % Change (10 year annual rate):-2.8%
- Total Return to Investors (last year):32.8%
- Total Return to Investors (5 year, annualized):20.9%
- Total Return to Investors (10 year, annualized):19.2%
- Founded:2013
- Sites:53
- Industry Vertical:Biotechnology
AbbVie stock chart
AbbVie in Fortune Rankings
- Fortune 500
- Fortune Global 500
- Best Large Workplaces in Chicago
- America's Most Innovative Companies
- World's Most Admired Companies
- Fortune 100 Best Companies to Work For
- Fortune 100 Best Companies To Work For – Southeast Asia
- World’s 25 Best Workplaces
- 100 Best Large Workplaces for Women
- Fortune 100 Best Companies To Work For – Europe
- Best Large Workplaces in Biotechnology and Pharmaceuticals
- Best Large Workplaces for Parents
- Fortune Sector Leaders: Health Care
- 100 Best Large Workplaces for Millennials















